Biotechnology argenx Receives Positive CHMP Opinion for Efgartigimod for the Treatment of Adult Patients with Generalized Myasthenia Gravis in Europe June 24, 2022
Biotechnology AXSM LOSS ALERT: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AXSM June 23, 2022
Biotechnology CLASS ACTION UPDATE for RSKD, AXSM and SPRO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders June 23, 2022
Biotechnology Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of ACADIA Pharmaceuticals, Inc. (ACAD) Investigation June 23, 2022
Biotechnology BioNTech Receives Priority Medicines (PRIME) Designation from EMA for Enhanced Regulatory Support of CAR-T Candidate BNT211 in Testicular Cancer June 23, 2022
Search
biotech investors
